TCLI.F Stock Overview
Designs and markets high-tech therapeutic ultrasound equipment. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Theraclion SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.32 |
| 52 Week High | €0.32 |
| 52 Week Low | €0.00017 |
| Beta | 0.070 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | -70.91% |
| Change since IPO | -78.67% |
Recent News & Updates
Recent updates
Shareholder Returns
| TCLI.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | 1.5% | 2.2% |
| 1Y | n/a | 20.8% | 31.6% |
Return vs Industry: Insufficient data to determine how TCLI.F performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how TCLI.F performed against the US Market.
Price Volatility
| TCLI.F volatility | |
|---|---|
| TCLI.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 8.1% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: TCLI.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine TCLI.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 28 | Martin Deterre | www.theraclion.com |
Theraclion SA designs and markets high-tech therapeutic ultrasound equipment. It offers SONOVEIN, a robotic solution for non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment and protects the patient’s skin and optimizes the image quality. Theraclion SA was incorporated in 2004 and is based in Malakoff, France.
Theraclion SA Fundamentals Summary
| TCLI.F fundamental statistics | |
|---|---|
| Market cap | US$17.54m |
| Earnings (TTM) | -US$3.71m |
| Revenue (TTM) | US$1.34m |
13.1x
P/S Ratio-4.7x
P/E RatioIs TCLI.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TCLI.F income statement (TTM) | |
|---|---|
| Revenue | €1.28m |
| Cost of Revenue | €3.07m |
| Gross Profit | -€1.78m |
| Other Expenses | €1.78m |
| Earnings | -€3.56m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.077 |
| Gross Margin | -139.01% |
| Net Profit Margin | -277.68% |
| Debt/Equity Ratio | 240.9% |
How did TCLI.F perform over the long term?
See historical performance and comparison